- 1. RC-160
- (UMLS (NCI) C0072994) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 4. RCMD-RS
- [A myelodysplastic syndrome characterized by bi-cytopenia or pancytopenia, dysplastic changes in 10% or more of the cells in two or more of the myeloid cell lines, and 15% or more ringed sideroblasts in the bone marrow. (WHO, 2001) — 2003 ( NCI )] (UMLS (NCI) C1301356) Refractory Cytopenia with Multilineage Dysplasia and Ringed Sideroblasts =Neoplastic Process
|
- 2. rCD4
- [A recombinant human soluble CD4 with antiviral activity. Recombinant human soluble CD4 has the amino terminus but not the T-cell binding domain of the endogenous CD4 antigen. This soluble CD4 protein competitively binds to envelope glycoprotein (gp120) of human immunodeficiency virus (HIV) resulting in inhibition of interaction between gp120 and the endogenous CD4 antigen, thereby blocking viral recognition of CD4 and subsequent entry of HIV into CD4 bearing cells. ( NCI )] (UMLS (NCI) C0279074) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 5. RCN2
- [This gene is involved in calcium-binding processes. ( NCI )] (UMLS (NCI) C1335606) RCN2 Gene;
Reticulocalbin 2, EF-Hand Calcium Binding Domain Gene;
=Gene or Genome ;
|
- 3. RCMD
- [A myelodysplastic syndrome characterized by bi-cytopenia or pancytopenia and dysplastic changes in 10% or more of the cells in two or more of the myeloid cell lines. A minority of cases progress to acute myeloid leukemia. (WHO, 2001) ( NCI )] (UMLS (NCI) C0796466) Refractory Cytopenia with Multilineage Dysplasia;
=Neoplastic Process | |
home
